as 05-09-2025 4:00pm EST
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
Founded: | 1992 | Country: | United States |
Employees: | N/A | City: | FORT WORTH |
Market Cap: | 1.5B | IPO Year: | 2001 |
Target Price: | $45.83 | AVG Volume (30 days): | 725.6K |
Analyst Decision: | Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.45 | EPS Growth: | N/A |
52 Week Low/High: | $22.66 - $55.75 | Next Earning Date: | 05-06-2025 |
Revenue: | $1,135,755,000 | Revenue Growth: | 3.00% |
Revenue Growth (this year): | 3.75% | Revenue Growth (next year): | 4.42% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
LIPPS RANDALL A | OMCL | CHAIRMAN, PRESIDENT AND CEO | Mar 14 '25 | Buy | $33.13 | 10,561 | $349,874.31 | 333,610 |
OMCL Breaking Stock News: Dive into OMCL Ticker-Specific Updates for Smart Investing
Simply Wall St.
11 hours ago
Zacks
2 days ago
Simply Wall St.
2 days ago
StockStory
3 days ago
StockStory
3 days ago
GuruFocus.com
3 days ago
Thomson Reuters StreetEvents
3 days ago
Argus Research
3 days ago
The information presented on this page, "OMCL Omnicell Inc. ($0.001 par value) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.